IP Library Granted Patent US 11,220,514
Granted Patent B2
US 11,220,514 · App. 16/624,491 · Granted Jan 11, 2022

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Inventors: Allan Carsten Dahl (Ballerup, DK); Johan Eriksson Bajtner (Ballerup, DK); Esben Paul Krogh Olsen (Ballerup, DK); Bjørn Metzler (Ballerup, DK)
Assignee: UNION therapeutics A/S
C07D495/10B01J21/16C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,220,514
App. No.
16/624,491
Granted
Jan 11, 2022
Kind
B2
Abstract

The present invention relates to novel methods for the preparation of 1,3-benzodioxole heterocyclic compounds of formula (I). The compounds are useful as PDE4 inhibitors.

Claims (32)

1. A method for the preparation of a compound of formula (I)

wherein R 1 is CHF 2 , and Q is selected from chloro, bromo and fluoro, comprising:

(1) reacting a compound of formula (II)

wherein R 2 is selected from, C 1-6 -alkyl and arylalkyl, and R 21 is C(O)CH 3 ; with a compound of formula (III)

in the presence of an acid catalyst in the form of a clay or a zeolite, to form a compound of formula (IV)

wherein R 2 and R 21 are as defined above;

(2a) reacting the compound of formula (IV)

wherein R 2 and R 21 are as defined above with an aliphatic or aromatic thiol in the presence of a metal hydroxide in a suitable solvent to obtain a compound of formula (VI)

wherein R 21 is as defined above;

(3′) reacting the compound of formula (VI),

wherein R 21 is as defined above, by addition of a solution of the compound of formula (VI) and sodium chlorodifluoro acetate in N,N-dimethylformamide (DMF) to a pre-heated mixture of DMF, water and potassium carbonate to obtain the compound of formula (IX),

wherein R 1 and R 21 are as defined above;

(4) reacting the compound of formula (IX) with a pyridine compound of formula (X)

wherein Q is as defined above and Q X is selected from chloro, bromo, fluoro, and iodo, to form a compound of formula (XI);

wherein R 1 and Q are as defined above; and

(5) oxidizing the resulting compound of formula (XI) to prepare the compound of formula (I).

2. The method according to claim 1 wherein the metal hydroxide in (2a) is NaOH.

3. The method according to claim 1 wherein the reaction in (2a) is performed using NaOH, 1-dodecanethiol, and ethanol.

4. The method according to claim 1 wherein the reaction in (2a) is performed using NaOH, 1-dodecanethiol, and 1-propanol.

5. The method according to claim 1 , where in the reaction in (3′) the compound of formula (IX) is isolated by the use of trifluoroacetic acid (TFA) or methanesulfonic acid (MSA) in DMF, at elevated temperature and subsequent removal by treatment with an aqueous base.

6. The method according to claim 5 , wherein the aqueous base is chosen from KOH and NaOH.

7. The method according to claim 1 , wherein the reaction in (4) is conducted in a solvent of DMF/tBuOH and using tert-BuOK as base.

8. The method according to claim 7 wherein the solvent of DMF/tBuOH is a 30/70 v/v mixture.

9. The method according to claim 1 where in the reaction in (5) the compound of formula (I) is crystalized directly from the concentrated reaction mixture.

10. The method according to claim 1 wherein each Q and each Q X are chloro.

11. The method according to claim 1 wherein in the reaction in (1) the acid catalyst is the silicate material Montmorillonite K10.

12. A method for preparing a compound of formula (I)

wherein R 1 in formula (I) is selected from CHF 2 and CF 3 , Q in formula (I) is selected from chloro, bromo and fluoro, comprising reacting a compound of formula (IX)

wherein R 21 is C(O)CH 3 , with a pyridine compound of formula (X)

wherein Q X is selected from chloro, bromo, fluoro, and iodo, to form a compound of formula (XI);

wherein the reaction is conducted in a solvent of DMF/tBuOH and a base of tert-BuOK.

13. The method according to claim 12 wherein the solvent of DMF/tBuOH is a 30/70 v/v mixture.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: LEO PHARMA A/S
To: UNION THERAPEUTICS A/S
Reel/Frame 060701/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2021
From: LEO PHARMA A/S
To: UNION THERAPEUTICS A/S
Reel/Frame 056769/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: DAHL, ALLAN CARSTEN; BAJTNER, JOHAN ERIKSSON; OLSEN, ESBEN PAUL KROGH; METZLER, BJORN
To: LEO PHARMA A/S
Reel/Frame 053109/0425 →
Priority Claims (1)
EP 17176767 · Jun 20, 2017 · regional
Continuity (1)
Related Publication 20210147440A1 · May 20, 2021
Cited By (1)
US 12,409,172